New Director starts at The Roslin Institute

Professor Eleanor Riley takes up the role of Institute Director on 1st September 2017.

Image
Eleanor Riley

We are pleased to welcome Professor Eleanor Riley as the new Director of The Roslin Institute as of today.

Professor Riley has a background in veterinary medicine, human infectious diseases and global health. She has over 30 years of research experience including leading major multi-partner projects in the UK and Africa.

I am honoured and delighted to have been given the opportunity to lead The Roslin Institute. I look forward to guiding the Institute to continued success and to strengthening research collaborations at home and abroad.

Professor Eleanor Riley

Professor Riley succeeds Professor David Hume, who stepped down from the role of Director in January. Since then Professor Bruce Whitelaw, previously the Institute's Head of Division of Developmental Biology, has been serving as Interim Director.

Professor Riley’s CV at a glance

Since 2017

  • Director of the Roslin Institute at the University of Edinburgh
  • Professor of Immunology and Infectious Disease and Dean for Research, Royal (Dick) School of Veterinary Studies
  • Deputy Chair of the MRC Infections and Immunity Board
2014-2017
  • Chair of the BBSRC Bioscience for Health Strategy Advisory Panel

2001 – 2013

  • Head of the Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, University of London

1998 – 2017

  • Professor of Infectious Disease Immunology, London School of Hygiene and Tropical Medicine, University of London

1990 – 1998

  • Wellcome Trust Senior Research Fellow, Biological Sciences, University of Edinburgh

1985 – 1990

  • Senior Scientist, MRC Laboratories, The Gambia
  • PhD, Parasitology/Immunology, University of Liverpool

1980     

  • MRCVS, Membership of the Royal College of Veterinary Surgeons
  • BVSc, Veterinary Science, University of Bristol

1978     

  • BSc, Cellular Pathology, University of Bristol

 

 

 

 

 

 

 

 

 

 

 

 

 

For further information, please contact: